Kyverna Therapeutics (KYTX) Long-Term Debt Repayments (2023 - 2026)
Kyverna Therapeutics (KYTX) recorded Long-Term Debt Repayments of $95,000 in Q2 2026, down 63.7% from $262,000 a year earlier but up 10.5% from the prior quarter.
Powered by 
Analysis
Kyverna Therapeutics (KYTX) Long-Term Debt Repayments (2023 - 2026) Analysis & Trends
On a TTM basis, Kyverna Therapeutics' Long-Term Debt Repayments came in at $386,000 as of Jun 30, 2026, down 64.6% year-over-year; for FY2025, it was $808,000, down 15.5% from FY2024.
- Across earlier years, Long-Term Debt Repayments came in at $956,000 in FY2024 (+22.4%) and $781,000 in FY2023.
- Quarterly Long-Term Debt Repayments has ranged from $85,000 in Q4 2025 to $341,000 in Q1 2025 over the past five years.
- On a year-over-year basis, Long-Term Debt Repayments has declined for four consecutive quarters, with an average decline of 21.2% over the last eight quarters.
- Peak year-over-year performance for Long-Term Debt Repayments in the last five years was growth of 47.6% in Q1 2025, against a decline of 74.8% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $86,000 (Q1 2026), $85,000 (Q4 2025) and $120,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -4.91 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.05 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 19.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Kyverna Therapeutics | 312.78 Mn | -573.60 Mn | - | 95,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 95,000.00 |
| Mar 31, 2026 | 86,000.00 |
| Dec 31, 2025 | 85,000.00 |
| Sep 30, 2025 | 120,000.00 |
| Jun 30, 2025 | 262,000.00 |
| Mar 31, 2025 | 341,000.00 |
| Dec 31, 2024 | 247,000.00 |
| Sep 30, 2024 | 241,000.00 |
| Jun 30, 2024 | 245,000.00 |
| Mar 31, 2024 | 231,000.00 |
| Dec 31, 2023 | 219,000.00 |
| Sep 30, 2023 | 206,000.00 |
| Jun 30, 2023 | 187,000.00 |
| Mar 31, 2023 | 168,000.00 |
API Access
Kyverna Therapeutics Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=KYTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "KYTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=KYTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();